Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
| dc.contributor.author | White, Desley | |
| dc.contributor.author | Adams, P | |
| dc.contributor.author | Altes, A | |
| dc.contributor.author | et al, | |
| dc.date.accessioned | 2018-03-29T08:11:22Z | |
| dc.date.issued | 2018-03-27 | |
| dc.identifier.issn | 1936-0533 | |
| dc.identifier.issn | 1936-0541 | |
| dc.identifier.uri | http://hdl.handle.net/10026.1/11209 | |
| dc.description.abstract |
Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles. | |
| dc.format.extent | 83-86 | |
| dc.format.medium | Print-Electronic | |
| dc.language | en | |
| dc.language.iso | en | |
| dc.publisher | Springer Verlag | |
| dc.subject | Chelation Therapy | |
| dc.subject | Diet | |
| dc.subject | Female | |
| dc.subject | Hemochromatosis | |
| dc.subject | Hemochromatosis Protein | |
| dc.subject | Homozygote | |
| dc.subject | Humans | |
| dc.subject | Male | |
| dc.subject | Phlebotomy | |
| dc.title | Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype | |
| dc.type | journal-article | |
| dc.type | Editorial | |
| dc.type | Practice Guideline | |
| plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000430317500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
| plymouth.issue | 2 | |
| plymouth.volume | 12 | |
| plymouth.publication-status | Published | |
| plymouth.journal | Hepatology International | |
| dc.identifier.doi | 10.1007/s12072-018-9855-0 | |
| plymouth.organisational-group | /Plymouth | |
| plymouth.organisational-group | /Plymouth/Faculty of Health | |
| plymouth.organisational-group | /Plymouth/Faculty of Health/School of Health Professions | |
| plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
| plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy | |
| plymouth.organisational-group | /Plymouth/Research Groups | |
| plymouth.organisational-group | /Plymouth/Research Groups/Institute of Health and Community | |
| plymouth.organisational-group | /Plymouth/Users by role | |
| plymouth.organisational-group | /Plymouth/Users by role/Academics | |
| dc.publisher.place | United States | |
| dcterms.dateAccepted | 2018-03-15 | |
| dc.identifier.eissn | 1936-0541 | |
| dc.rights.embargoperiod | No embargo | |
| rioxxterms.versionofrecord | 10.1007/s12072-018-9855-0 | |
| rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
| rioxxterms.licenseref.startdate | 2018-03-27 | |
| rioxxterms.type | Journal Article/Review |
